Clinical Trial

Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma

Study acronym: VDHCC
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2016 (before its estimated June 2016 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine whether vitamin D is effective in the prevention of hepatocellular carcinoma in those patients with chronic hepatitis B.
Trial Details
NCT Number NCT02779465
Lead Sponsor Third Affiliated Hospital, Sun Yat-Sen University
Conditions Hepatitis B, Carcinoma, Hepatocellular
Enrollment 1,500 participants
Start Date 2016-06
Primary Completion 2016-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2016-05-20